Masahiro Yoshino

Prognostic Factors in Patients with Gemcitabine-Refractory Pancreatic Cancer (2007)

Nakachi, Kohei, Furuse, Junji, Ishii, Hiroshi, Suzuki, Ei-ichiro, Yoshino, Masahiro

Objective The purpose of this study was to identify prognostic factors in patients with gemcitabine-refractory pancreatic cancer and to determine criteria for selecting candidates for second-line...

Prognostic Factors in Patients with Gemcitabine-Refractory Pancreatic Cancer (2007)

Nakachi, Kohei, Furuse, Junji, Ishii, Hiroshi, Suzuki, Ei-ichiro, Yoshino, Masahiro

Objective The purpose of this study was to identify prognostic factors in patients with gemcitabine-refractory pancreatic cancer and to determine criteria for selecting candidates for second-line...

Primary Tumor of Pancreatic Cancer as a Measurable Target Lesion in Chemotherapy Trials (2005)

Ishii, Hiroshi, Furuse, Junji, Nakachi, Kouhei, Suzuki, Ei-ichiro, Yoshino, Masahiro

Background: It is unclear whether primary pancreatic cancer (PC) tumors can be accepted as measurable target lesions in chemotherapy trials. We reviewed recent PC patients to clarify the significance...

Treatment Cost of Pancreatic Cancer in Japan: Analysis of the Difference after the Introduction of Gemcitabine (2005)

Ishii, Hiroshi, Furuse, Junji, Kinoshita, Taira, Konishi, Masaru, Nakagohri, Toshio, Takahashi, Shinichiro, ...

Background: Recent advances in cancer chemotherapy have increased not only the survival rate but also the treatment cost, although there has been little interest in cost analyses in Japan. Method:...

Primary Tumor of Pancreatic Cancer as a Measurable Target Lesion in Chemotherapy Trials (2005)

Ishii, Hiroshi, Furuse, Junji, Nakachi, Kouhei, Suzuki, Ei-ichiro, Yoshino, Masahiro

Background: It is unclear whether primary pancreatic cancer (PC) tumors can be accepted as measurable target lesions in chemotherapy trials. We reviewed recent PC patients to clarify the significance...

Phase I Study of Fixed Dose Rate Infusion of Gemcitabine in Patients with Unresectable Pancreatic Cancer (2005)

Furuse, Junji, Ishii, Hiroshi, Okusaka, Takuji, Nagase, Michitaka, Nakachi, Kohei, Ueno, Hideki, ...

Objective: The purpose of this study was to determine the feasible dose of gemcitabine when administered as a fixed dose rate infusion (10 mg/m2/min) on a weekly schedule to Japanese patients with...

Treatment Cost of Pancreatic Cancer in Japan: Analysis of the Difference after the Introduction of Gemcitabine (2005)

Ishii, Hiroshi, Furuse, Junji, Kinoshita, Taira, Konishi, Masaru, Nakagohri, Toshio, Takahashi, Shinichiro, ...

Background: Recent advances in cancer chemotherapy have increased not only the survival rate but also the treatment cost, although there has been little interest in cost analyses in Japan. Method:...

Phase I Study of Fixed Dose Rate Infusion of Gemcitabine in Patients with Unresectable Pancreatic Cancer (2005)

Furuse, Junji, Ishii, Hiroshi, Okusaka, Takuji, Nagase, Michitaka, Nakachi, Kohei, Ueno, Hideki, ...

Objective: The purpose of this study was to determine the feasible dose of gemcitabine when administered as a fixed dose rate infusion (10 mg/m2/min) on a weekly schedule to Japanese patients...

Treatment Cost of Pancreatic Cancer in Japan: Analysis of the Difference after the Introduction of Gemcitabine (2005)

Ishii, Hiroshi, Furuse, Junji, Kinoshita, Taira, Konishi, Masaru, Nakagohri, Toshio, Takahashi, Shinichiro, ...

Background: Recent advances in cancer chemotherapy have increased not only the survival rate but also the treatment cost, although there has been little interest in cost analyses in Japan. Method:...

Primary Tumor of Pancreatic Cancer as a Measurable Target Lesion in Chemotherapy Trials (2005)

Ishii, Hiroshi, Furuse, Junji, Nakachi, Kouhei, Suzuki, Ei-ichiro, Yoshino, Masahiro

Background: It is unclear whether primary pancreatic cancer (PC) tumors can be accepted as measurable target lesions in chemotherapy trials. We reviewed recent PC patients to clarify the significance...

Phase I Study of Fixed Dose Rate Infusion of Gemcitabine in Patients with Unresectable Pancreatic Cancer (2005)

Furuse, Junji, Ishii, Hiroshi, Okusaka, Takuji, Nagase, Michitaka, Nakachi, Kohei, Ueno, Hideki, ...

Objective: The purpose of this study was to determine the feasible dose of gemcitabine when administered as a fixed dose rate infusion (10 mg/m2/min) on a weekly schedule to Japanese patients with...

Extrahepatic Spread from Hepatocellular Carcinoma: Who are Candidates for Aggressive Anti-cancer Treatment? (2004)

Ishii, Hiroshi, Furuse, Junji, Kinoshita, Taira, Konishi, Masaru, Nakagohri, Toshio, Takahashi, Shinichiro, ...

Background: There is no standard treatment for patients with extrahepatic spread from hepatocellular carcinoma. The aim of this retrospective study was to identify candidates for aggressive...

Herbicide-resistant late watergrass (Echinochloa phyllopogon): similarity in morphological and amplified fragment length polymorphism traits (2003)

Ryouichirou Tsuji, Albert J. Fischer, Masahiro Yoshino, Alvaro Roel, James E. Hill, Yuji Yamasue

Late watergrass is a serious weed of California rice that has evolved resistance to molinate, thiobencarb, fenoxaprop-ethyl, and bispyribac-sodium. To obtain an insight into the origin and spread of...

A Phase I Study of Hepatic Arterial Infusion Chemotherapy with Zinostatin Stimalamer Alone for Hepatocellular Carcinoma (2003)

Ishii, Hiroshi, Furuse, Junji, Nagase, Michitaka, Maru, Yasushi, Yoshino, Masahiro, Hayashi, Takayuki

Background: Hepatic arterial infusion of zinostatin stimalamer and lipiodol emulsion shows a moderate activity against hepatocellular carcinoma. However, the anti-tumor activity of zinostatin...

Changes in Mode of Response to Chemotherapy for Hepatocellular Carcinoma Induced by Transarterial Embolization. A Case Report (1991)

Okazaki, Nobuo, Yoshida, Takanobu, Yoshino, Masahiro, Okada, Shuichi, Shimada, Yasuhiro, Moriyama, Noriyuki, ...

A 61-year-old man received systemic mitoxantrone chemotherapy following transarterial embolization of a large hepatocellular carcinoma with extensive intrahepatic, lung and bone metastases. His serum...

Pilot Phase II Study of Cis-diamminedichioroplatinum (II) against Metastatic Gastric Cancers (1990)

Miyamoto, Kengo, Yoshidal, Shigeaki, Saito, Daizo, Shimada, Yasuhiro, Tajiri, Hisao, Yamaguchi, Hajime, ...

Fifty patients with metastatic gastric cancer were entered for a phase II study of Cisdiamminedichloroplatinum (II) (CDDP), 45 of whom were able to have their responses evaluated. CDDP was given...

Preoperative Ultrasonography Screening for Liver Metastases of Patients with Colorectal Cancer (1989)

Yoshida, Takanobu, Matsue, Hiroto, Suzuki, Michihiro, Okazaki, Nobuo, Yoshino, Masahiro, Moriya, Yashihiro, ...

The clinical value of preoperative ultrasonography in screening for synchronous liver metastases was prospectively evaluated in 338 patients with colorectal cancer. Synchronous liver metastases were...

A Phase II Study of Etoposide in Patients with Hepatocellular Carcinoma by the Tokyo Liver Cancer Chemotherapy Study Group (1989)

Yoshino, Masahiro, Okazaki, Nobuo, Yoshida, Takanobu, Kanda, Yozo, Miki, Makoto, Oda, Hiroyuki, ...

Twenty-four patients with hepatocellular carcinoma were treated with 80 mg etoposide /m2 for five consecutive days at 4-week intervals. Of the 21 patients evaluated, only one showed a partial...

Phase II Study of Orally and Rectally Administered Tegafur in Liver Metastases from Gastric Carcinoma (1984)

REYES, JOSE M., OKAZAKI, NOBUO, YOSHINO, MASAHIRO, YOSHIDA, TAKANOBU

Twenty-four eligible and evaluable patients with measurable liver metastases from gastric cancer were treated with oral or rectal Tegafur. Objective responses were seen in 8 of the patients...

Growth Kinetics of Hepatocellular Carcinoma (1983)

YOSHINO, MASAHIRO

We measured the size of 17 semispherical hepatocellular carcinoma tumor nodules in 13 patients repeatedly by either computed tomography or ultrasonography for 10 to 291 days. At the initial...

Serum Beta-lipoproteins in Patients with Hepatocellular Carcinoma (1980)

YOSHINO, MASAHIRO

Serum β-lipoprotein was precipitated solely by the use of relatively low molecular weight (7,000–8,000) dextran sulfate. The following studies were conducted with β-lipoprotein purified by this...

Ultrasonographic Diagnosis of Malignant Hepatic Tumors (1980)

YOSHIDA, TAKANOBU, OKAZAKI, NOBUO, YOSHINO, MASAHIRO, MATSUE, HIROTO, KISHI, KIYOZO

Forty-two patients with liver malignancies were examined with the U.I. Octoson ultrasonographic scanner. The cases were divided into four groups according to the ultrasonographic patterns. About...

A Case of Hepatoblastoma in Adult (1979)

YOSHIDA, TAKANOBU, OKAZAKI, NOBUO, YOSHINO, MASAHIRO, SHIMAMURA, YOSHIYUKI, MIYAZAWA, NAOTO, MIYAMOTO, KANEATSU, ...

A rare case of hepatoblastoma in a 60-year-old man is reported. The first sign of his illness was metastasis found as a tumor on the left fifth rib. There were no laboratory or angiographic findings...

Peritoneoscopic Findings of Hepatocellular Carcinoma (1978)

OKAZAKI, NOBUO, YOSHINO, MASAHIRO, YOSHIDA, TAKANOBU, KANDA, YUZO

The peritoneoscopy was carried out on 44 patients with hepatocellular carcinoma and the obtained 55 color photographs of different tumor nodules were analyzed. In general, the hepatocellular...

A Case of Hepatocellular Carcinoma Developed on Polycystic Disease of the Liver with Cirrhosis (1978)

YOSHINO, MASAHIRO, OKAZAKI, NOBUO, YOSHIDA, TAKANOBU, OZAKI, HIDEO, KISHI, KIYOZO

A case of hepatocellular carcinoma associated with polycystic disease of the liver and posthepatitic cirrhosis in a 56-year-old Korean woman was described. She was first admitted because of...

Diagnostic Evaluation of Serum Lipids in Patients With Hepatocellular Carcinoma (1977)

YOSHIDA, TAKANOBU, OKAZAKI, NOBUO, YOSHINO, MASAHIRO, ARAKI, EIJI

Levels of various classes of lipids in the serum were determined in patients with hepatocellular carcinoma, liver cirrhosis, and healthy controls. Serum total cholesterol, esterified cholesterol,...

Metastatic Pattern and Length of Survival in Patients With Liver Metastasis From Gastric Cancer (1977)

OKAZAKI, NOBUO, SETO, TERUKAZU, KANDA, YUZO, YOSHINO, MASAHIRO, YOSHIDA, TAKANOBU

The relationship of the gross patterns of cancer distribution in the liver to the survival length was evaluated in 35 autopsy cases with liver metastasis from gastric cancer. The factor responsible...

Peritoneoscopic Classification of Cavernous Hemangiomas of the Liver (1977)

YOSHINO, MASAHIRO, OKAZAKI, NOBUO, YOSHIDA, TAKANOBU

The peritoneoscopic findings of cavernous hemangiomas of the liver observed in seven cases were classified into the following four types. Type I: Patches, mostly disseminated. Dark or purplish blue...